Landscapes / Companies
Jina Pharmaceuticals Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
4
in active trials · 5 in all
Trials
4 active
6 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved in India | — | |||
| Also tested for | Triple Negative Breast Cancer | ||||
| Open drug page | |||||
Taxane derivative |
Phase 3 | — | |||
| How it works | Taxane chemotherapy | ||||
| Also tested for | Platinum-Resistant Primary Peritoneal Carcinoma, Platinum Resistant High Grade Epithelial Ovarian Cancer and 1 more | ||||
| Open drug page | |||||
Oral cabazitaxelnot checked |
Taxane derivative |
Phase 2 | Dec 2026Phase 2 trial completes | ||
| How it works | Taxane chemotherapy | ||||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Metastatic Castration-resistant Prostate Cancer, MCRPC | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate | ||||
| Open drug page | |||||
About
- No active trial
- Endoxifen enteric-coated
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021